Cargando…

Vaccination of susceptible animals against SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Xiang, Bin, Yang, Liangyu, Ye, Zaijiao, Ren, Tao, Ye, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905880/ https://www.ncbi.nlm.nih.gov/pubmed/35278484 http://dx.doi.org/10.1016/j.jinf.2022.03.005

Ejemplares similares

Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2
por: Zeng, Chuan, et al.
Publicado: (2022)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
por: Kong, Qi, et al.
Publicado: (2020)

Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)

Vocal fold palsy after vaccination against SARS-CoV-2()
por: Lehrer, Eduardo, et al.
Publicado: (2022)

Chronic spontaneous urticaria following vaccination against SARS-CoV-2()
por: Zaiem, Ahmed, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Mosaic vaccination schedule: An unexpected card to play against SARS-CoV-2?
por: Ricco, Matteo, et al.
Publicado: (2021)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Predictive Analysis of Susceptibility of Different Species to SARS-CoV-2 based on ACE2 Receptors
por: XU, Xiao Gang, et al.
Publicado: (2020)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
por: Inserra, Felipe, et al.
Publicado: (2021)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing maintenance hemodialysis
por: Delgado Ureña, Ana, et al.
Publicado: (2023)

Pinpointing the animal origins of SARS-CoV-2: a genomic approach
por: Zhao, Shilei, et al.
Publicado: (2022)

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
por: Tu, Bin, et al.
Publicado: (2022)

Unfolding issues of immunity against SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

Acute myopericarditis after administration of mRNA vaccines against the SARS-CoV-2 virus()
por: Gómez Martín, Alba María, et al.
Publicado: (2022)

Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection
por: Favresse, Julien, et al.
Publicado: (2023)

Comment on: A rare case of cortical blindness following vaccination against SARS-CoV-2
por: Finsterer, Josef, et al.
Publicado: (2023)

Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionarily Successful One?
por: Voskarides, Konstantinos
Publicado: (2020)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
por: Khayat-Khoei, Mahsa, et al.
Publicado: (2021)

Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines
por: al Jalali, Valentin, et al.
Publicado: (2021)

Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination
por: Hsu, Lea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u55rlj6esa9sr52cjeclfj805l